Understanding graft-induced dyskinesia

Lane, Emma Louise ORCID: https://orcid.org/0000-0001-8800-3764 and Smith, Gaynor A. ORCID: https://orcid.org/0000-0003-4332-8383 2010. Understanding graft-induced dyskinesia. Regenerative Medicine 5 (5) , pp. 787-797. 10.2217/rme.10.42

Full text not available from this repository.

Abstract

The transplantation of dopaminergic cells for the treatment of symptoms of Parkinson’s disease has several hurdles to overcome before it can be considered a successful therapeutic approach. One issue is the development of abnormal involuntary movements in the absence of L-3,4-dihydroxyphenylalanine following the transplantation of fetal ventral mesencephalon identified in three different clinical trials. Hypotheses as to the cause of these movements include: the composition of the graft, size of the graft, L-3,4-dihydroxyphenylalanine exposure and L-3,4-dihydroxyphenylalanine-induced dyskinesia prior to transplantation and inflammatory responses in and around the graft. We evaluate the clinical evidence supporting these hypotheses and the preclinical models upon which experiments are being based to resolve them.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences Pharmacy
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords:	6-hydroxydopamine-lesioned rat; graft-induced dyskinesia; Parkinson's disease; transplantation; ventral mesencephalon
Publisher:	Future Medicine
ISSN:	1746-0751
Last Modified:	18 Oct 2022 13:37
URI:	https://orca.cardiff.ac.uk/id/eprint/14627

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item